PDF factsheet
      Z

fibrinolysis in cardiac arrest for all type of patients, clinical trials results

t-PA versus placebo
Abu-Laban, 2002
t-PA 100mg over a 15-minute period
versus
placebo
Victims of cardiac arrest with pulseless electrical activity for more than one minute and had had no palpable pulse for more than three minutes during resuscitative efforts and at the time of the initiation of the study drugdouble blind
Canda
tenecteplase versus placebo
TROICA, 2008
NCT00157261
tenecteplase (dose according to estimated body weight)
versus
placebo
adults with witnessed out-of-hospital cardiac arrest of presumed cardiac origin and with initiation of basic or advanced life support within 10 minutes after collapsedoubel blind
Follow-up duration: 30 days
Europe
TICA, 2004
tenecteplase 50 mg
versus
placebo
All victims of out of hospital cardiac arrestdouble blind
Australia

  Options


in first

in second

  Filter